Skip to main content

Table 1 Pharmacokinetic parameters of riociguat in plasma following a single oral dose of riociguat 1 mg

From: Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment

Parameter

Child–Pugh A (n = 16)

Child–Pugh B (n = 16)

Control A (n = 16)

Control B (n = 16)

AUC, μg·h/L

371.0 (74)

458.9 (62)

349.9 (67)

300.9 (92)

Cmax, μg/L

42.67 (37)

43.27 (39)

42.67 (23)

38.68 (30)

AUCnorm, kg·h/L

30.9 (75)

36.6 (65)

29.1 (67)

23.9 (94)

Cmax,norm, kg/L

3.56 (33)

3.45 (26)

3.55 (20)

3.07 (23)

t½, h

9.19 (53)

13.7 (50)

9.02 (63)

7.54 (86)

  1. Values are geometric means (percentage coefficient of variation). AUC, area under the plasma concentration–time curve from time 0 to infinity; AUCnorm, AUC divided by dose per kilogram of body weight for total riociguat; Cmax, maximum concentration in plasma; Cmax,norm, Cmax divided by dose per kilogram of body weight for total riociguat; t½, terminal elimination half-life for total riociguat.